Michael McDonell, PhD

Personal Statement

My primary interest is on determining how behavioral technologies can be used to improve alcohol and drug abuse outcomes for those suffering from addiction health disparities. Behavioral technologies are non-talk therapy approaches to addiction treatment, such as motivational incentives where we provide rewards for people who abstain from or reduce their drinking. This low-cost, strength based approach to addiciton can be implimented in low-resources settings by non clinicians. In fact, our group is investigating how smartphones might be used to impliment this treatment, allowing us to reach the millions of individuals suffering from alcohol problems worldwide.  

My second research interest in evaluating the accuracy of alcohol biomarkers in addiction treatment settings. These include alcohol urine tests, such as ethyl glucuronide (EtG) and mobile phone linked Bluetooth breathalyzers. These tools allow us to accurately assess  the sucess of alcohol treatments, as well as provide valuable research tools.      

Importantly all of my ressearch studies are conducted in collaboration with two communities that suffer dispproporationately high rates of alcohol and drug miuse, 1) adults with severe mental illnesses, like schizophrenia and bipolar disorder and 2) American Indians and Alaska Natives. My reserach team and I work closely with community partners who are providing addiction treatment to these populations with the goal of reducing the burden of alcohol and drug use in these communities. 

Recent Publications

An Unexplored Equity Factor During Pre-Implementation of Contingency Management: Differential Beliefs and Attitudes by Providers' Ethnicity.
(2023 Apr 18)
Res Sq
Oluwoye O, Weeks DL, McDonell MG

Aniqsaaq (To Breathe): Study protocol to develop and evaluate an Alaska Native family-based financial incentive intervention for smoking cessation.
(2023 Jun)
Contemp Clin Trials Commun 33(): 101129
Patten CA, Koller KR, King DK, Prochaska JJ, Sinicrope PS, McDonell MG, Decker PA, Lee FR, Fosi JK, Young AM, Sabaque CV, Brown AR, Borah BJ, Thomas TK

Patient Feedback on a Mobile Medication Adherence App for Buprenorphine and Naloxone: Closed and Open-Ended Survey on Feasibility and Acceptability.
(2023 Apr 19)
JMIR Form Res 7(): e40437
Smith CL, Keever A, Bowden T, Olson K, Rodin N, McDonell MG, Roll JM, Smoody G, LeBrun J, Miguel AQ, McPherson SM

Cannabis for Healing in a Native Community Clinic: Development and Results from an Informatics Research Tool.
(2023 Apr 17)
J Psychoactive Drugs
Lyons AJ, Kordas G, Smith ET, Wilson M, Matheson M, Shelton A, Owens M, Iiams-Hauser K, McDonell MG

Expanding access to treatment for stimulant use disorder in a frontier state: A qualitative study of contingency management and TRUST program implementation in Montana.
(2023 Apr 13)
J Subst Use Addict Treat
Green B, Parent S, Ware J, Hasson AL, McDonell M, Nauts T, Collins M, Kim F, Rawson R

Show complete publication list »
Edit Profile